Alpine Woods Capital Investors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.12M Buy
23,064
+4,003
+21% +$1.43M 1.95% 9
2025
Q4
$6.24M Sell
19,061
-1,259
-6% -$399K 1.49% 15
2025
Q3
$5.73M Sell
20,320
-3,840
-16% -$1.11M 1.33% 19
2025
Q2
$6.75M Sell
24,160
-1,093
-4% -$310K 1.6% 15
2025
Q1
$7.87M Sell
25,253
-4,218
-14% -$1.25M 1.97% 7
2024
Q4
$7.68M Sell
29,471
-3,561
-11% -$1.06M 1.45% 15
2024
Q3
$10.6M Sell
33,032
-3,913
-11% -$1.28M 1.86% 11
2024
Q2
$11.5M Buy
36,945
+11,209
+44% +$3.29M 1.78% 10
2024
Q1
$7.05M Sell
25,736
-4,675
-15% -$1.37M 1.4% 19
2023
Q4
$8.76M Buy
30,411
+504
+2% +$137K 1.31% 17
2023
Q3
$8.04M Sell
29,907
-1,633
-5% -$408K 1.3% 21
2023
Q2
$7M Sell
31,540
-545
-2% -$126K 1.09% 30
2023
Q1
$7.76M Sell
32,085
-2,838
-8% -$697K 1.17% 26
2022
Q4
$9.17M Buy
34,923
+2,152
+7% +$577K 1.34% 21
2022
Q3
$7.39M Sell
32,771
-271
-0.8% -$65.7K 1.01% 35
2022
Q2
$8.04M Sell
33,042
-88
-0.3% -$21.6K 1.01% 34
2022
Q1
$8.01M Sell
33,130
-1,382
-4% -$318K 0.84% 42
2021
Q4
$7.76M Buy
34,512
+2,023
+6% +$427K 0.77% 44
2021
Q3
$6.91M Sell
32,489
-2,424
-7% -$558K 0.74% 49
2021
Q2
$8.51M Buy
34,913
+323
+0.9% +$79.5K 0.88% 37
2021
Q1
$8.61M Buy
34,590
+2,197
+7% +$524K 0.95% 27
2020
Q4
$7.45M Buy
32,393
+1,795
+6% +$414K 0.91% 30
2020
Q3
$7.78M Buy
30,598
+10,248
+50% +$2.54M 1.18% 16
2020
Q2
$4.8M Buy
20,350
+3,411
+20% +$778K 0.92% 20
2020
Q1
$3.43M Buy
16,939
+2,625
+18% +$573K 0.76% 29
2019
Q4
$3.45M Sell
14,314
-106
-0.7% -$23.4K 0.65% 37
2019
Q3
$2.79M Sell
14,420
-115
-0.8% -$22.1K 0.51% 42
2019
Q2
$2.68M Buy
14,535
+228
+2% +$40.8K 0.56% 46
2019
Q1
$2.72M Buy
14,307
+77
+0.5% +$14.7K 0.59% 37
2018
Q4
$2.77M Sell
14,230
-570
-4% -$111K 0.66% 36
2018
Q3
$3.07M Sell
14,800
-100
-0.7% -$19.7K 0.63% 39
2018
Q2
$2.75M Sell
14,900
-6,850
-31% -$1.21M 0.6% 45
2018
Q1
$3.71M Hold
21,750
0.2% 132
2017
Q4
$3.78M Sell
21,750
-1,200
-5% -$212K 0.19% 141
2017
Q3
$4.28M Sell
22,950
-2,800
-11% -$496K 0.22% 132
2017
Q2
$4.43M Hold
25,750
0.24% 128
2017
Q1
$4.22M Sell
25,750
-1,050
-4% -$174K 0.22% 129
2016
Q4
$3.92M Buy
26,800
+900
+3% +$135K 0.22% 133
2016
Q3
$4.32M Hold
25,900
0.24% 120
2016
Q2
$3.94M Buy
25,900
+1,000
+4% +$155K 0.24% 120
2016
Q1
$3.83M Buy
24,900
+1,800
+8% +$267K 0.22% 126
2015
Q4
$3.75M Buy
23,100
+1,600
+7% +$251K 0.2% 136
2015
Q3
$2.97M Sell
21,500
-250
-1% -$39.4K 0.16% 146
2015
Q2
$3.34M Buy
21,750
+1,050
+5% +$168K 0.17% 142
2015
Q1
$3.31M Buy
20,700
+50
+0.2% +$7.88K 0.17% 141
2014
Q4
$3.29M Sell
20,650
-2,900
-12% -$452K 0.17% 135
2014
Q3
$3.31M Sell
23,550
-100
-0.4% -$13.1K 0.18% 127
2014
Q2
$2.8K Buy
23,650
+7,550
+47% +$874K 0.07% 132
2014
Q1
$1.99M Sell
16,100
-200
-1% -$24.3K 0.11% 153
2013
Q4
$1.86M Buy
16,300
+5,400
+50% +$614K 0.11% 153
2013
Q3
$1.22M Buy
+10,900
New +$1.18M 0.08% 177

Other funds holding AMGN

Alpine Woods Capital Investors's AMGN Position: Q1 2026 in Review

Alpine Woods Capital Investors increased its Amgen (AMGN) stake by 21% in Q1 2026, buying an estimated $1.43M and bringing the position to 23,064 shares worth $8.12M. The position accounts for 1.95% of the portfolio, ranked #9.

Alpine Woods Capital Investors first reported a position in AMGN in Q3 2013 and has held it in 51 quarters since. The position peaked at $11.5M in Q2 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Alpine Woods Capital Investors held 23,064 shares of Amgen worth $8.12M as of Q1 2026.
  • Alpine Woods Capital Investors bought 4,003 Amgen shares in Q1 2026, an estimated $1.43M.
  • Amgen made up 1.95% of Alpine Woods Capital Investors's portfolio in Q1 2026, its #9 holding.
  • Alpine Woods Capital Investors first reported a position in Amgen in Q3 2013 and has held it in 51 quarters since.
  • Alpine Woods Capital Investors's Amgen position peaked at $11.5M in Q2 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2026, filed 27 May 2026.